Ugur Ozerdem1. 1. La Jolla Institute for Molecular Medicine, San Diego, California 92121, USA. ozerdem@ljimm.org
Abstract
BACKGROUND: The walls of capillaries in prostate cancer are composed of endothelial cells, and pericytes. NG2 is a transmembrane proteoglycan on nascent pericytes with a functional role in neovascularization. METHODS: The anti-angiogenic effect of hydron pellets containing NG2 neutralizing antibody was quantified in intracorneal PC-3 and LNCaP xenografts. TRAMP and TRAMP-C1 tumors grafted in NG2 knockout mice represented intrinsic pericyte targeting. TRAMP and TRAMP-C1 grafts were analyzed with confocal microscope for microvascular density (MVD) and lymphatic vascular density (LVD). RESULTS: NG2 neutralizing antibody decreased corneal neovascularization in PC3 (P<0.0001), and LNCaP (P=0.0079) xenografts. Mean MVD in TRAMP and TRAMP-C1 tumors in NG2 knockout mice were 71% (P=0.0006) and 63% (P=0.0011) lower than wild type controls, respectively. Mean LVD in TRAMP and TRAMP-C1 tumors in NG2 knockout mice were 73% (P=0.0003) and 84% (P<0.0001) lower than wild type controls, respectively. CONCLUSIONS: Targeting of pericyte-NG2 decreases neovascularization and lymphangiogenesis in prostate cancer significantly. Copyright (c) 2005 Wiley-Liss, Inc.
BACKGROUND: The walls of capillaries in prostate cancer are composed of endothelial cells, and pericytes. NG2 is a transmembrane proteoglycan on nascent pericytes with a functional role in neovascularization. METHODS: The anti-angiogenic effect of hydron pellets containing NG2 neutralizing antibody was quantified in intracorneal PC-3 and LNCaP xenografts. TRAMP and TRAMP-C1 tumors grafted in NG2 knockout mice represented intrinsic pericyte targeting. TRAMP and TRAMP-C1 grafts were analyzed with confocal microscope for microvascular density (MVD) and lymphatic vascular density (LVD). RESULTS:NG2 neutralizing antibody decreased corneal neovascularization in PC3 (P<0.0001), and LNCaP (P=0.0079) xenografts. Mean MVD in TRAMP and TRAMP-C1 tumors in NG2 knockout mice were 71% (P=0.0006) and 63% (P=0.0011) lower than wild type controls, respectively. Mean LVD in TRAMP and TRAMP-C1 tumors in NG2 knockout mice were 73% (P=0.0003) and 84% (P<0.0001) lower than wild type controls, respectively. CONCLUSIONS: Targeting of pericyte-NG2 decreases neovascularization and lymphangiogenesis in prostate cancer significantly. Copyright (c) 2005 Wiley-Liss, Inc.
Authors: Peter C Stapor; Richard S Sweat; Derek C Dashti; Aline M Betancourt; Walter Lee Murfee Journal: J Vasc Res Date: 2014-05-17 Impact factor: 1.934
Authors: Vesselina G Cooke; Valerie S LeBleu; Doruk Keskin; Zainab Khan; Joyce T O'Connell; Yingqi Teng; Michael B Duncan; Liang Xie; Genta Maeda; Sylvia Vong; Hikaru Sugimoto; Rafael M Rocha; Aline Damascena; Ricardo R Brentani; Raghu Kalluri Journal: Cancer Cell Date: 2012-01-17 Impact factor: 31.743
Authors: Feng-Ju Huang; Weon-Kyoo You; Paolo Bonaldo; Thomas N Seyfried; Elena B Pasquale; William B Stallcup Journal: Dev Biol Date: 2010-06-27 Impact factor: 3.582
Authors: Sabrina Cattaruzza; Ugur Ozerdem; Martin Denzel; Barbara Ranscht; Pietro Bulian; Ugo Cavallaro; Daniela Zanocco; Alfonso Colombatti; William B Stallcup; Roberto Perris Journal: Angiogenesis Date: 2012-11-04 Impact factor: 9.596